Measuring stimulation and inhibition of intracellular nitric oxide production in SIM-A9 microglia using microfluidic

Jay Sibbitts1, Christopher T Culbertson

  • 1Department of Chemistry, Kansas State University, 1212 Mid-Campus Drive, 213 CBC Building, Manhattan, KS, USA. culbert@ksu.edu.

Insights

This study introduces a microfluidic device for measuring nitric oxide (NO) in microglial cells, crucial for understanding neurodegenerative diseases. The device accurately quantifies NO production, aiding in the development of new therapeutic strategies.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Microfluidics

Background:

  • Chronic neuroinflammation accelerates neurodegenerative diseases like Alzheimer's and Parkinson's.
  • Microglia-produced nitric oxide (NO) contributes to neuronal damage and apoptosis.
  • Measuring microglial NO is challenging due to its short half-life and cell heterogeneity.

Purpose of the Study:

  • To develop and apply a microfluidic device for high-throughput intracellular NO measurement in microglial cells.
  • To assess NO production in response to inflammatory stimuli and iNOS inhibition.
  • To validate the device's sensitivity and statistical analysis methods.

Main Methods:

  • Utilized a microfluidic device for SIM-A9 microglial cells.
  • Measured intracellular NO using DAF-FM DA probe and 6-CFDA standard.
  • Employed microchip electrophoresis and laser-induced fluorescence detection (LIF).
  • Applied refractive index matching gel to enhance detection sensitivity.

Main Results:

  • Demonstrated a 1.6-fold increase in NO production upon stimulation with LPS and IFN-γ.
  • Showed a 0.5-fold decrease in NO production with iNOS inhibition (1400 W dihydrochloride).
  • Confirmed lognormal distribution for NO production, supporting geometric mean analysis.
  • Reported improved sensitivity of the optical fiber-based detection system.

Conclusions:

  • The microfluidic device enables accurate, high-throughput measurement of microglial NO.
  • This technology can aid in evaluating therapeutics targeting neuroinflammation and iNOS.
  • The findings contribute to a better understanding of neuroinflammation in neurodegenerative disease progression.

Related Concept Videos